Table 3.
Diagnostic applications of EV mRNA cargoes. Disease biomarker changes reported with respect to controls.
| Indication | EV Source | EV Isolation Method | EV Size | Biomarker | Source | |
|---|---|---|---|---|---|---|
| Cancer | Colorectal Cancer | Culture media of Colorectal cancer cell lines (SW620, Wi-Dr, LS174T, HCT116) Normal colon fibroblast (CCD-18Co) |
Ultracentrifugation | - | ↑ VEGF ↑ CD133 |
43 |
| Human Plasma | Immuno-magnetic bead pull-down (CD9, CD63, and CD81) |
|||||
| Prostate Cancer | Human Plasma | Precipitation Ultracentrifugation Iodixanol velocity gradient Immunocapture |
~100 nm | ↑ AR-V7 ↑ EV size (~200 nm) |
45 | |
| Non-small Cell Lung Cancer | Human Bronchoalveolar Lavage Fluid | Ultracentrifugation | ~50-200 nm | ↑ EGFR ↑ KRAS ↑ ALK ↑ MET ↑ LKB1 ↑ PIK3CA ↑ ROS1 |
46 | |
| Infectious Diseases | Enzootic Bovine Leukosis | Bovine Milk | Successive filtration (1.0, 0.45, and 0.2 μm-pore-size) Ultracentrifugation |
~100 nm | ↑ TMEM1156 ↑ SRGN ↑ CXCL8 ↑ DEFB4A ↑ FABP5 ↑ LAPM5 ↑ LGALS1 ↑ VIM |
153. |
| Neurological Diseases | Alzheimer's Disease | Human Plasma | - | - | ↑ MT-CO3 ↑ MT-ND1 ↑ MT-ND4 ↑ MT-ND2 ↑ MT-ATP6 ↑ MT-ND4 ↑ MT-CYTB ↑ MT-ND ↑ MT-NTP ↑ MT-ND5 ↑ MT-C01 ↑ MT-ND6 |
63 |
| Culture media of microglia (HMC3) astrocytoma (1321N1) neuroblastoma (BE(2)-M17) primary embryonic cortical neurons |
Ultracentrifugation | ~100-300 nm (astrocytes only) | ||||
| Autism Spectrum Disorder | Human Plasma | Precipitation | 50-150 nm | ↑ SYT1 loci ↑ SYT9 loci ↑ SYP loci ↓ SV2C |
71 | |
| Autism Spectrum Disorder | Human Serum | Precipitation L1CAM immuno- pulldown |
~40-150 nm | ↑ EV concentration ↑ EDNRA ↓ HTR3A |
77 | |
| Postpartum Depression | Human Plasma | Membrane affinity spin columns | - | (In third trimester) ↑ CD72 ↑ KYNU |
80 | |
| ↑ Total mRNA concentration in third trimester, followed by ↓ after birth | ||||||
| Obstetric Indications | Antenatal Hydronephrosis | Human Amniotic Fluid | Size exclusion chromatography Ultracentrifugation |
~75-200 nm | ↑ Moesin | 88 |